Orexigen’s anti-obesity pill wins FDA Approval

The FDA has approved Orexigen’s anti-obesity pill, but despite the good news, shares of the drug maker declined today. What’s holding investors back?

This entry was posted in Biotech & Pharmaceuticals, NBR Show Clips. Bookmark the permalink.

Leave a Reply